Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00849108 · ClinicalTrials.gov registry record · Phase 2
Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158
A Phase 2 study, sponsored by Lantheus Medical Imaging.
- Completed
- Registry status
- Phase 2
- Development phase
- 176
- Enrollment target
NCT00849108 is a Phase 2 study that has completed, run by Lantheus Medical Imaging. The registered enrollment target is 176 participants.
The verdict
NCT00849108, a Phase 2 study, has completed, sponsored by Lantheus Medical Imaging.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 176 participants
- Enrollment target
Study Summary
The main purpose of this study is to get more information on using BMS747158 (the study drug),a drug with small amounts of radioactivity to allow for heart imaging, during a PET scan which can then be compared to other images such as SPECT. The safety and quality of images will be studied.
Interventions
- DRUG BMS747158
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00849108
The ClinicalTrials.gov registry entry for NCT00849108 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lantheus Medical Imaging, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BMS747158 is the first listed.
NCT00849108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00849108 about?
NCT00849108 is a clinical study titled "Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158". The main purpose of this study is to get more information on using BMS747158 (the study drug),a drug with small amounts of radioactivity to allow for heart imaging, during a PET scan which can then be compared to other images such as SPECT. The safety and quality of images will be studied.
What is the current status of trial NCT00849108?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 176 participants. The study started on 2009-01. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00849108?
The interventions under investigation include: BMS747158 (DRUG).
Who is sponsoring clinical trial NCT00849108?
This trial is sponsored by Lantheus Medical Imaging, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.